- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02320838
Unmodulated 5 Kilohertz Currents Versus TENS: Effect on Pain Thresholds, Tactile Threshold, and Nerve Conduction
Unmodulated 5 Kilohertz Alternating Currents Versus TENS: Effect on Mechanical and Thermal Pain Thresholds, Tactile Threshold, and Peripheral Nerve Conduction in Humans.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
In the last years several animal experimental studies have evidenced that high frequency unmodulated currents about 5 KHz can cause a peripheral nerve block. However electric currents with these high frequencies that are usually used for the treatment of pain in humans are interrupted or modulated (i.e. interferential currents)
This evidences in animals could have application in pain treatment, characterized by overactive nervous system. For this reason it was decided to compare the effects on experimental pain and peripheral nerve conduction of this new electric current versus sham stimulation and TENS (Transcutaneous Electrical Nerve Stimulation).
The scientific literature on transcutaneous electrical stimulation in humans and changes in nerve conduction and / or somatosensory thresholds focuses mainly on TENS (Transcutaneous Electrical Nerve Stimulation). Therefore TENS is a good reference standard to compare the effect of this new currents.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Participants will be volunteer healthy students of Physiotherapy, University of Castilla - La Mancha, older than 18 years.
Exclusion Criteria:
- Neuromuscular disease.
- Epilepsy.
- Trauma, surgery or pain affecting the upper limb, shoulder girdle or cervical area.
- Osteosynthesis material in the upper limb.
- Diabetes.
- Cancer.
- Cardiovascular disease.
- Pacemaker or other implanted electrical device.
- Take any drug (NSAIDs, corticosteroids, antidepressants, analgesics, antiepileptics, ...) during the study and in the previous 7 days.
- Presence of tattoos or other external agent introduced into the treatment or assessment area.
- Pregnancy.
- Sensitivity disturbance in upper limb.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: 5 KHz
Transcutaneous application of 5 KHz current over the course of the superficial radial nerve in the right forearm for a 20 minutes session.
The intensity of the current will increase until participants report a "strong but comfortable" sensation, just below motor threshold.
|
5 KHz transcutaneous electrical stimulation over superficial radial nerve through the electrotherapy device Myomed 932.
(Enraf-Nonius, Delft, Netherlands)
|
|
Experimental: TENS
Transcutaneous application of Conventional TENS current over the course of the superficial radial nerve in the right forearm for a 20 minutes session.
The intensity of the current will increase until participants report a "strong but comfortable" sensation, just below motor threshold.
Currents parameters are frequency 110 Hz and pulse width 200 microseconds
|
TENS transcutaneous electrical stimulation over superficial radial nerve through the electrotherapy device Myomed 932.
(Enraf-Nonius, Delft, Netherlands)
|
|
Sham Comparator: Sham Stimulation
Electrodes are placed over the course of the superficial radial nerve in the right forearm for a 20 minutes in the same manner as experimental groups, but will be applied a sham electrical stimulation increasing the current intensity of an unconnected channel.
|
Sham transcutaneous electrical stimulation over superficial radial nerve through the electrotherapy device Myomed 932.
(Enraf-Nonius, Delft, Netherlands)
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Mechanical Pain Threshold During Treatment
Time Frame: during treatment at 15 min
|
The pressure pain threshold will be measured by a pressure algometer and will be expressed in Newton
|
during treatment at 15 min
|
|
Thermal Pain Threshold During Treatment
Time Frame: during treatment at 15 min.
|
The heat pain threshold will be measured by a computer controlled thermo-foil heating device and will be expressed in ºC
|
during treatment at 15 min.
|
|
Nerve Conduction Latency Immediately After Treatment
Time Frame: immediately after treatment at 20 min.
|
The compound action potential latencies will be measured and will be expressed in ms.
|
immediately after treatment at 20 min.
|
|
Tactile Threshold During Treatment
Time Frame: during treatment at 15 min.
|
The tactile threshold will be measured with Von Frey filaments and will be expressed in millinewton
|
during treatment at 15 min.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Habituation to Electrical Stimulation
Time Frame: Start treatment session (1 min), end treatment session (20 min)
|
The habituation to electrical stimulation along experimental session will be measured by recording the difference on current intensity (mA) at the start of the treatment session (1 min) and end of the same (20 min)
|
Start treatment session (1 min), end treatment session (20 min)
|
|
Perception Current Comfortability
Time Frame: At the end of the third experimental session, 3 days
|
Participants will choose the current treatment that has found more comfortable
|
At the end of the third experimental session, 3 days
|
|
Change Current Density (mA/cm2)
Time Frame: at 1 min. treatment session, at 20 min. treatment session
|
Change in current density (mA/cm2), it will be recorded at 1 min.
start of the treatment session and at 20 min of the same.
|
at 1 min. treatment session, at 20 min. treatment session
|
|
Change From Baseline in Nerve Conduction Amplitude ( µV)
Time Frame: Baseline,immediately after treatment at 20 min..
|
The compound action potential amplitudes ( µV) will be measured.
|
Baseline,immediately after treatment at 20 min..
|
|
Baseline Mechanical Pain Threshold
Time Frame: Baseline at 0 min.
|
The pressure pain threshold will be measured by a pressure algometer and will be expressed in Newton
|
Baseline at 0 min.
|
|
Mechanical Pain Threshold Post-treatment 20 Min.
Time Frame: at 20 min. post-treatment
|
The pressure pain threshold will be measured by a pressure algometer and will be expressed in Newton
|
at 20 min. post-treatment
|
|
Mechanical Pain Threshold Post-treatment 40 Min.
Time Frame: at 40 min. post-treatment
|
The pressure pain threshold will be measured by a pressure algometer and will be expressed in Newton.
|
at 40 min. post-treatment
|
|
Baseline Thermal Pain Threshold
Time Frame: Baseline at 0 min.
|
The heat pain threshold will be measured by a computer controlled thermo-foil heating device and will be expressed in ºC
|
Baseline at 0 min.
|
|
Thermal Pain Threshold Post-treatment 20 Min.
Time Frame: at 20 min. post-treatment
|
The heat pain threshold will be measured by a computer controlled thermo-foil heating device and will be expressed in ºC
|
at 20 min. post-treatment
|
|
Thermal Pain Threshold Post-treatment 40 Min.
Time Frame: at 40 min. post-treatment
|
The heat pain threshold will be measured by a computer controlled thermo-foil heating device and will be expressed in ºC
|
at 40 min. post-treatment
|
|
Baseline Nerve Conduction Latency
Time Frame: Baseline at 0 min.
|
The compound action potential latencies will be measured and will be expressed in ms.
|
Baseline at 0 min.
|
|
Nerve Conduction Latency Post-treatment 20 Min.
Time Frame: at 20 min. post-treatment
|
The compound action potential latencies will be measured and will be expressed in ms.
|
at 20 min. post-treatment
|
|
Nerve Conduction Latency Post-treatment 40 Min.
Time Frame: at 40 min. post-treatment
|
The compound action potential latencies will be measured and will be expressed in ms.
|
at 40 min. post-treatment
|
|
Baseline Tactile Threshold
Time Frame: Baseline at 0 min.
|
The tactile threshold will be measured with Von Frey filaments and will be expressed in millinewton
|
Baseline at 0 min.
|
|
Tactile Threshold Post-treatment 20 Min.
Time Frame: at 20 min. post-treatment
|
The tactile threshold will be measured with Von Frey filaments and will be expressed in millinewton
|
at 20 min. post-treatment
|
|
Tactile Threshold Post-treatment 40 Min.
Time Frame: at 40 min. post-treatment
|
The tactile threshold will be measured with Von Frey filaments and will be expressed in millinewton
|
at 40 min. post-treatment
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Skin Temperature
Time Frame: Baseline, during treatment at 15 min., immediately after treatment at 20 min., at 20 min. post-treatment, at 40 min. post-treatment
|
Skin temperature (ºC) will be recorded in all assessment times.
|
Baseline, during treatment at 15 min., immediately after treatment at 20 min., at 20 min. post-treatment, at 40 min. post-treatment
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Juan Avendaño-Coy, MsC, University of Castilla-La Mancha, Toledo, Spain
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- javendano
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pain
-
Flowonix MedicalApproved for marketingBack Pain | Leg Pain | Trunk Pain | Intractable Pain | Arm Pain
-
Boston Scientific CorporationRecruitingLow Back Pain | Chronic Pain | Chronic Low-back Pain | Leg Pain | Intractable Pain | Chronic Leg PainUnited States
-
Universitat Jaume ICompletedPain, Acute | Pain, Chronic | OncologySpain
-
University Hospital Schleswig-HolsteinZealand University Hospital; European Regional Development Fund; Design School...CompletedPain, Acute | Pain, Chronic | Pain Measurement | Pain, CancerGermany
-
Qi's ClinicNot yet recruitingNon-Cancer Pain,Musculoskeletal Pain,Chronic Pain,Acute Pain
-
University of Campinas, BrazilCompletedPREGNANCY | LUMBAR BACK PAIN | PELVIC PAIN
-
noiVita SrlsUniversity of Eastern PiedmontCompletedCervical Pain | Pain Management | Lumbar Pain | Muscular | Chronic Pain (Back / Neck)Italy
-
Chinese University of Hong KongNot yet recruitingPain, Acute | Chronic Post Operative Pain | Pain, ChronicHong Kong
-
Dow University of Health SciencesRecruitingLow Back Pain | Chronic Low-back Pain | Low Back Pain, Mechanical | Mechanical Low Back Pain | Pain, Chronic | Pain, Back | Lower Back Pain Chronic | CLBP - Chronic Low Back PainPakistan
-
University of SaskatchewanRoyal University Hospital FoundationCompletedPain | Pain, Acute | Pain, Chronic | Pain, IntractableCanada
Clinical Trials on 5 KHz
-
Nevro CorpActive, not recruitingPainful Diabetic NeuropathyUnited States
-
Cairo UniversityCompleted
-
University of Castilla-La ManchaHospital Nacional de Parapléjicos de ToledoCompletedNeuropathic Pain | Spinal Cord Injuries (SCI)Spain
-
University of Castilla-La ManchaCastilla-La Mancha Health Service; Hospital General Nuestra Señora del Prado; Indiba S.A...CompletedSubacromial Impingement Syndrome | Shoulder Impingement SyndromeSpain
-
University of MalagaNot yet recruitingAchilles Tendon | Achilles Tendon InjurySpain
-
University of Castilla-La ManchaUnknown
-
University of Castilla-La ManchaCompletedElectrical Stimulation | NeuromodulationSpain
-
Fundacio Espai SalutHospital Clinic of Barcelona; Corporación Fisiogestión S.A.; Agència d'Avaluació...Unknown
-
Government College of Dentistry, IndoreCompletedPeriodontitis | Coronary Heart Disease
-
University of Castilla-La ManchaCompletedElectrical Stimulation | NeuromodulationSpain